[Intravenous use of nitrazepam (Mogadan) in the treatment of epilepsy].
D000284:Administration, Oral; D001552:Benzazepines / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D004569:Electroencephalography; D004827:Epilepsy / Q000139:chemically induced; D004832:Epilepsy, Absence / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007275:Injections, Intravenous; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000188:drug therapy; D010787:Photosensitivity Disorders / Q000188:drug therapy; D012640:Seizures / Q000150:complications; D013036:Spasms, Infantile / Q000209:etiology / Q000503:physiopathology
D001552:Benzazepines; D006993:Hypnotics and Sedatives; D003975:Diazepam
Deintravenöse Anwendung von Nitrazepam (Mogadan) in der Epilepsiebehandlung.